Alnylam Pharmaceuticals
ALNY
#618
Rank
โ‚น2.779 T
Marketcap
โ‚น21,473
Share price
3.69%
Change (1 day)
79.37%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company